Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Disabil Rehabil ; 38(3): 218-22, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-25875049

RESUMEN

PURPOSE: The aims of this pilot were to examine dance as a feasible intervention for persons with multiple sclerosis (MS), specifically to examine issues of tolerability and its longitudinal effects on participants. Dance is an enjoyable physical activity that has been investigated in other neurodegenerative populations but has yet to be studied in MS. METHOD: A 4-week, two 60-min classes per week, pilot salsa dance intervention was administered to eight individuals with MS. The outcomes measured were effects on gait, balance, self-efficacy, motivation, physical activity and MS symptoms. They were administered at baseline, immediately post-intervention and at 3- and 6-month follow-ups. RESULTS: Statistically significant pre-post intervention gains were found for the Timed Up and Go Test (TUG), Dynamic Gait Index (DGI), Activities-specific Balance Confidence Scale and Godin Leisure Time Questionnaire. Significant improvements were also found for the TUG, DGI and MS Walking Scale between baseline and 3-month follow-up assessments. Participants did not report any problems with fatigue or intolerability with the 60-min suggestions, further supporting the feasibility for the concept of a dance intervention. CONCLUSIONS: This study suggests that dance for persons with MS may have promise for improving physical activity, gait and balance. IMPLICATIONS FOR REHABILITATION: Although structured dance has reported benefits in elderly populations and in individuals with cardiovascular and neurological impairments, there is virtually nothing known regarding dance in the MS population. This pilot salsa dance study shows that structured dance demonstrates promise of being well-tolerated, safe and effective at promoting physical activity in people with MS without increased fatigue. A 12-week study has been initiated to test the robustness of initial observations and further examine factors influencing participants' physical activity adherence and behavioral change.


Asunto(s)
Danzaterapia/métodos , Motivación , Actividad Motora , Esclerosis Múltiple/rehabilitación , Equilibrio Postural , Autoeficacia , Adulto , Femenino , Marcha , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Calidad de Vida , Encuestas y Cuestionarios , Resultado del Tratamiento
2.
Mult Scler ; 11(1): 33-40, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15732264

RESUMEN

Multiple sclerosis (MS) is a chronic illness of the central nervous system, with a highly variable clinical course. Available therapies are only partially effective and as a consequence treatment patterns between patients can be varied. Longitudinal databases consisting of large cohorts where successive and sequential data is collected may reveal disease and treatment characteristics not apparent when data is gathered during clinical trials that consist usually of relatively homogeneous patients followed for short durations. We analysed data from the North American Research Committee on Multiple Sclerosis registry, a self-reported database, to assess MS patient characteristics and treatment patterns, with a focus on veterans. We show that the Veteran Healthcare Administration (VHA) system of medical centres care for a greater number of patients with higher average disability but not necessarily patients who report primary progressive or actively worsening disease. We also show that the VHA medical centres appear to better provide multidisciplinary care, particularly in the areas of social work, physical therapy and urology. In general, treatment patterns for symptomatic therapies follow similar patterns across veterans and non-veterans groups. Treatment patterns for immunomodulatory agents suggest that VHA veterans use IMA less frequently than either non-VHA veterans or non-veterans.


Asunto(s)
Esclerosis Múltiple Crónica Progresiva/tratamiento farmacológico , Esclerosis Múltiple Crónica Progresiva/epidemiología , Esclerosis Múltiple Recurrente-Remitente/tratamiento farmacológico , Esclerosis Múltiple Recurrente-Remitente/epidemiología , Sistema de Registros , Veteranos/estadística & datos numéricos , Adyuvantes Inmunológicos/uso terapéutico , Adulto , Analgésicos/uso terapéutico , Terapias Complementarias , Depresión/tratamiento farmacológico , Depresión/epidemiología , Evaluación de la Discapacidad , Fatiga/tratamiento farmacológico , Fatiga/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Espasticidad Muscular/tratamiento farmacológico , Espasticidad Muscular/epidemiología , Dolor/tratamiento farmacológico , Dolor/epidemiología , Grupo de Atención al Paciente , Prevalencia , Análisis de Regresión , Distribución por Sexo , Estados Unidos , United States Department of Veterans Affairs , Enfermedades de la Vejiga Urinaria/tratamiento farmacológico , Enfermedades de la Vejiga Urinaria/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA